BeOne Medicines (BeiGene)
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 approved
4 in Phase 3
Drugs
31
in active trials · 59 in all
Trials
68 active
187 since 2021
Drugs31
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Nov 2026soonPhase 1/2 trial completes | |||
| Next date | Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma and 34 more | ||||
| Open drug page | |||||
PD-1 antibody |
Approved | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Urothelial Carcinoma and 27 more | ||||
| Open drug page | |||||
Kinase inhibitor |
Approved | Nov 2026soonPhase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Chronic Lymphocytic Leukemia, CLL and 18 more | ||||
| Open drug page | |||||
PARP inhibitor |
Approved in China | — | |||
| How it works | Blocks PARP | ||||
| Also tested for | Ovarian Cancer | ||||
| Open drug page | |||||
— |
Phase 3 | 31 Mar 2027Phase 1/2 trial completes | |||
| Next date | 31 Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Hepatocellular Carcinoma, Liver Cancer and 6 more | ||||
| Open drug page | |||||
— |
Phase 3 | Mar 2027Phase 1/2 trial completes | |||
| Next date | Mar 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Chronic Lymphocytic Leukemia, B-cell Malignancy and 18 more | ||||
| Open drug page | |||||
— |
Phase 3 | Apr 2029Phase 3 trial completes | |||
| Next date | Apr 2029 · Phase 3 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Hormone-receptor-positive Breast Cancer and 16 more | ||||
| Open drug page | |||||
— |
Phase 3 | 30 Nov 2029Phase 3 trial completes | |||
| Next date | 30 Nov 2029 · Phase 3 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Epithelial Ovarian Cancer and 2 more | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 1/2 | — | |||
| How it works | An antibody | ||||
| Also tested for | Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer | ||||
| Open drug page | |||||
Unmodified immunoglobulin |
Phase 1/2 | — | |||
| How it works | An antibody | ||||
| Also tested for | Urothelial Carcinoma, Renal Cell Carcinoma and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Jul 2027Phase 1 trial completes | |||
| Next date | 1 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jul 2027Phase 1 trial completes | |||
| Next date | 30 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Hormone-receptor-positive Breast Cancer, HER2-negative Breast Cancer and 1 more | ||||
| Open drug page | |||||
BON-107not checked |
— |
Phase 1 | 11 Oct 2027Phase 1 trial completes | ||
| Next date | 11 Oct 2027 · Phase 1 trial completes | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Nov 2027Phase 1 trial completes | |||
| Next date | 1 Nov 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumors, Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 29 Apr 2028Phase 1 trial completes | |||
| Next date | 29 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 23 Jul 2028Phase 1 trial completes | |||
| Next date | 23 Jul 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 8 Aug 2028Phase 1 trial completes | |||
| Next date | 8 Aug 2028 · Phase 1 trial completes | ||||
| Also tested for | Skin Diseases | ||||
| Open drug page | |||||
— |
Phase 1 | 29 Aug 2028Phase 1 trial completes | |||
| Next date | 29 Aug 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Aug 2028Phase 1 trial completes | |||
| Next date | 31 Aug 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
No drugs match “”.
About
- No active trial
- 28 other drugs
- SEC filings
- None: it does not file with the US SEC
- Registry names
- 3 names in ClinicalTrials.gov BeiGene
BeOne Medicines
BeiGene USA, Inc. - Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev